Clinical Trial Update: Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis [Phase 2]

View source ↗

Summary

Phase 2 trial of adoptive immunotherapy in relapsed hematological malignancies with early GVHD prophylaxis has completed enrollment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Hodgkin Lymphoma
• Lymphoid Leukemia
• Multiple Myeloma
• Myelogenous Leukemia
• Non-hodgkin Lymphoma

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Hodgkin's Lymphoma, Lymphoid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2023-01-23